Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-01 Option Award | 2024-01-03 5:14 pm | N/A 2033-12-31 | VYNE Therapeutics Inc. | VYNE | Sandoval Elisabeth Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-12-13 Option Award | 2023-12-15 5:06 pm | N/A 2033-12-12 | VYNE Therapeutics Inc. | VYNE | Sandoval Elisabeth Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-16 4:48 pm | N/A 2033-06-14 | PROCEPT BioRobotics Corp | PRCT | Sandoval Elisabeth Director | 7,576 | $0 | 14,512 (Direct) | View |
| 2023-06-08 Disposition | 2023-06-08 4:38 pm | N/A N/A | Satsuma Pharmaceuticals Inc. | STSA | Sandoval Elisabeth Director | 74,893 | $0 | 0 (Direct) | View |
| 2022-08-10 Option Award | 2022-08-12 5:12 pm | N/A 2032-08-10 | VYNE Therapeutics Inc. | VYNE | Sandoval Elisabeth Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-09 4:13 pm | N/A 2032-06-06 | PROCEPT BioRobotics Corp | PRCT | Sandoval Elisabeth Director | 4,205 | $0 | 11,141 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-09 4:13 pm | N/A N/A | PROCEPT BioRobotics Corp | PRCT | Sandoval Elisabeth Director | 2,001 | $37.48 | 11,141 (Direct) | View |
| 2022-06-03 Option Award | 2022-06-07 5:37 pm | N/A 2032-06-02 | Satsuma Pharmaceuticals Inc. | STSA | Sandoval Elisabeth Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2022-05-13 Equity Swap | 2022-05-16 6:39 pm | N/A 2031-04-04 | Intersect ENT Inc. | XENT | Sandoval Elisabeth Director | 15,896 | $28.25 | 0 (Direct) | View |
| 2021-10-21 Option Award | 2021-10-25 7:31 pm | N/A N/A | PROCEPT BioRobotics Corp | PRCT | Sandoval Elisabeth Director | 4,935 | $40.46 | 4,935 (Direct) | View |
| 2021-07-19 Option Award | 2021-07-20 5:06 pm | N/A 2031-07-19 | VYNE Therapeutics Inc. | VYNE | Sandoval Elisabeth Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2021-04-05 Option Award | 2021-04-07 6:18 pm | N/A 2031-04-04 | Intersect ENT Inc. | XENT | Sandoval Elisabeth Director | 15,896 | $0 | 15,896 (Direct) | View |
| 2020-12-03 Option Award | 2020-12-07 6:04 pm | N/A 2030-12-03 | Satsuma Pharmaceuticals Inc. | STSA | Sandoval Elisabeth Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2020-08-03 Option Award | 2020-08-05 4:39 pm | N/A 2030-08-03 | Menlo Therapeutics Inc. | MNLO | Sandoval Elisabeth Director | 22,500 | $0 | 22,500 (Direct) | View |
| 2020-06-12 Option Award | 2020-06-16 7:25 pm | N/A 2030-06-11 | Satsuma Pharmaceuticals Inc. | STSA | Sandoval Elisabeth Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2020-03-19 Option Award | 2020-03-23 4:45 pm | N/A 2030-03-19 | Menlo Therapeutics Inc. | MNLO | Sandoval Elisabeth Director | 45,000 | $0 | 45,000 (Direct) | View |
Ownership | 2019-09-12 4:53 pm | N/A 2029-05-23 | Satsuma Pharmaceuticals Inc. | STSA | Sandoval Elisabeth Director | 0 | $0 | 14,893 (Direct) | View |
| 2019-06-25 Option Award | 2019-06-27 4:15 pm | N/A 2029-03-19 | Menlo Therapeutics Inc. | MNLO | Sandoval Elisabeth Director | 11,645 | $0 | 45,000 (Direct) | View |